| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 41 |
| 1 | METHOTREXATE SODIUM | 28 |
| 2 | METHOTREXATE | 25 |
| 3 | TACROLIMUS | 19 |
| 4 | DOXORUBICIN | 17 |
| 5 | PREDNISONE | 17 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 7 | TACROLIMUS OINTMENT 0.1% | 17 |
| 8 | DEXAMETHASONE | 16 |
| 9 | DEXAMETHASONE 1.5 MG | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMIDUBICEL-ONLV | 2 | 0.0909 |
| 1 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 9 | 0.0262 |
| 2 | DEXRAZOXANE FOR INJECTION | 12 | 0.0127 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 12 | 0.0019 |
| 4 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 5 | CEFADROXIL | 3 | 0.0015 |
| 6 | VORINOSTAT | 2 | 0.0009 |
| 7 | DECITABINE | 4 | 0.0009 |
| 8 | PEGASPARGASE | 11 | 0.0009 |
| 9 | MICAFUNGIN SODIUM | 5 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 54 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 51 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 3 | Asparagine-specific Enzyme [EPC] | 20 |
| 4 | Alkylating Drug [EPC] | 15 |
| 5 | BCL-2 Inhibitor [EPC] | 14 |
| 6 | Fluoroquinolone Antibacterial [EPC] | 14 |
| 7 | Azole Antifungal [EPC] | 12 |
| 8 | Leukocyte Growth Factor [EPC] | 10 |
| 9 | Glycopeptide Antibacterial [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 20 | 0.0015 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 2 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 3 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 5 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | BCL-2 Inhibitor [EPC] | 14 | 0.0002 |
| 8 | Lipopeptide Antibacterial [EPC] | 2 | 0.0002 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |